ATARA Biotherapeutics (ATRA) Tops Q2 EPS by 19c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of $0.19. Revenue for the quarter came in at $17.58 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Daiwa Securities Downgrades JD.com, Inc (JD) to Hold
• Cushman & Wakefield names two capital markets leaders in APAC